The Relative Efficacies and Developments in Adjuvant and Neoadjuvant Therapy for Gastric Cancer - ReviewSami Ullah, Warda MohayUddin, Zafar Iqbal, Tong Dong and Wong Daorong*
Subei People’s Hospital of Jiangsu Province (Clinical Medical College of Yang Zhou University), Yangzhou 225001, Jiangsu Province, China
- *Corresponding Author:
- Daorong Wang
PhD, MD, Department of Gastrointestinal Surgery
Subei People's Hospital of Jiangsu Province
(The Clinical Medicine College of Yang Zhou Medical University)
Yangzhou 225001, P. R. China
E-mail: [email protected]
Received date: November 29, 2015 Accepted date: January 22, 2016 Published date: January 29, 2016
Citation: Ullah S, MohayUddin W, Iqbal Z, Dong T, Daorong W (2016) The Relative Efficacies and Developments in Adjuvant and Neoadjuvant Therapy for Gastric Cancer - Review. J Gastrointest Dig Syst 6:388. doi:10.4172/2161-069X.1000388
Copyright: © 2016 Ullah S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This present study examined the efficacy and developments in gastric cancer modalities. This is in light of the fact that gastric cancer accounts for a significant number of cancer related cases reported across the world. Moreover, it is contented that curative treatment is still poor because modalities have been studied, but they have all been yielding controversial results. The study establishes that all modalities are effective and this rule out the popular claims that they are infective. Surgery has been lauded to be the most effective modality for control of the malignant cells at their early stages of growth. It is unfortunate that most patients are diagnosed when the malignant cells are at the advanced stage; the late diagnosis results in high rates of relapses. With early strategies to improve the treatment modalities having failed, a series of studies have been undertaken and significant improvements have been realized. However, these approaches have some limitations. The improvement of outcomes in the deployment of these modalities rests upon future developments to address the underlying inadequacies. The strategies of gastric cancer management are so dynamic and are reflected by the ongoing studies on how to manage and contain the cancer menace.